why choose us

Clinical Trials Search

Showing 17,280 of 132,963 result(s)
Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Status: COMPLETED

Condition: Atrial Fibrillation With Rapid Ventricular Response

Interventions: The intervention is Calcium gluconate 1 gram;100ml 0.9% NaCl or 100ml 0.9% NaCl) over 5 minutes.

Date: 2022-12-15

Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

Status: COMPLETED

Condition: Cancer Pain

Interventions: Intrathecal drug delivery systems (IDDs) deliver small doses of analgesics directly to the spinal cord.

Date: 2022-12-14

Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome

Status: COMPLETED

Condition: Leukemia
Myeloid
Acute
Newly Diagnosed

Interventions: DRUG: MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70) monotherapy, Part 1 - MP0533 is administered by intravenous infusion

Date: 2022-12-14

OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness

Status: COMPLETED

Condition: Respiratory Tract Infections
Wheezing Lower Respiratory Illness

Interventions: DRUG: OM-85 - Subjects will be administered OM-85 3.5 mg capsules by mouth once daily. (10 days per month)
DRUG: Placebo - Subjects will be admin

Date: 2022-12-14

A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain

Status: ACTIVE_NOT_RECRUITING

Condition: Pain

Interventions: Tablets for oral administration.

Date: 2022-12-14

MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Status: Completed

Condition: Cancer

Interventions: FT538 IP at assigned dose level on Day 1, Day 8, and Day 15.

Date: 2022-12-14

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Status: Completed

Condition: Glioblastoma

Interventions: ITI-1001 DNA vaccine represents a multi-antigen nucleic acid cancer immunotherapy encoding 3 CMV antigens.
The vaccine is comprised of 2 DNA plas

Date: 2022-12-14

Maternal Oxygen Supplementation for Intrauterine Resuscitation

Status: Completed

Condition: Fetal Distress

Interventions: Maternal oxygen supplementation 10 liters;minute via nonrebreather mask

Date: 2022-12-14

Infrared Thermography-based Study of the Warming Effect Difference at Waist

Status: Completed

Condition: Health

Interventions: Patients allocated to the acupuncture group will be punctured at the pre-specified acupoints.
According to the theory of traditional Chinese medi

Date: 2022-12-14